
Annual report 2022
added 03-30-2023
Apollo Endosurgery Cash Flow 2011-2026 | APEN
Annual Cash Flow Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-31.3 M | -14.5 M | -20.8 M | -25.6 M | -23.1 M | -13.3 M | -12.9 M | -16 M | - | - | - | - |
Depreciation & Amortization |
1.21 M | 1.36 M | 1.78 M | 1.86 M | 2.02 M | 2.25 M | 1.86 M | 467 K | 216 K | 196 K | 188 K | 142 K |
Accounts Payables |
7.42 M | 4.58 M | 3.68 M | 9.9 M | 15.3 M | 18.3 M | 5.14 M | 294 K | 2.87 M | 2.03 M | 1.03 M | 2.22 M |
Accounts Receivables |
15 M | 10.1 M | 8.22 M | 9.23 M | 11.4 M | 11.7 M | 10.5 M | 6.99 K | 727 K | 1.31 M | 234 K | 1.33 M |
Total Inventories |
18.2 M | 12 M | 10.3 M | 8.86 M | 9.93 M | 14.3 M | 12.2 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -21 M | - | -8.69 M | - | -10.1 M | - | -4.31 M | - | -18 M | -13.3 M | -6.26 M | - | -18.9 M | -12.7 M | -6.06 M | - | -18.9 M | -16.2 M | -6.69 M | - | -9.68 M | -5.54 M | -3.45 M | - | -6.53 M | -4.74 M | -4.75 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | 316 K | - | 284 K | - | 285 K | 357 K | 429 K | - | 435 K | 453 K | 458 K | - | 436 K | 472 K | 503 K | - | 1.81 M | 1.8 M | 1.8 M | - | 1.8 M | 1.83 M | 1.81 M | - | 1.8 M | 1.82 M | 45.4 K | - | 262 K | 142 K | 70.6 K | - | 167 K | 98.9 K | 35.9 K | - | 161 K | 129 K | 42 K | - | 75 K | 47.2 K | 21.5 K | - | 65.8 K | 37.2 K | 21.4 K |
Accounts Payables |
- | 6.77 M | - | 6.4 M | 4.58 M | 4.51 M | 5.91 M | 4.58 M | 3.68 M | 3.68 M | 3.68 M | 3.68 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 13.6 M | 13.6 M | 13.6 M | 5.14 M | 4.68 M | 294 K | 294 K | 294 K | 2.87 M | 2.87 M | 2.87 M | 2.87 M | 2.03 M | 2.03 M | 2.03 M | 2.03 M | 1.03 M | 1.03 M | 1.03 M | 1.03 M | 2.22 M | 2.22 M | 2.22 M | 2.22 M |
Accounts Receivables |
- | 12.9 M | - | 11.1 M | 10.1 M | 10.3 M | 11.2 M | 9.46 M | 8.22 M | 8.22 M | 8.22 M | 8.22 M | 9.23 M | 9.23 M | 9.23 M | 9.23 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 6.99 K | 6.99 K | 6.99 K | 727 K | 727 K | 727 K | 727 K | 1.31 M | 1.31 M | 1.31 M | 1.31 M | 234 K | 234 K | 234 K | 234 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M |
Total Inventories |
- | 16.7 M | - | 13.3 M | 12 M | 11.3 M | 10.8 M | 10.5 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 8.86 M | 8.86 M | 8.86 M | 8.86 M | 9.93 M | 9.93 M | 9.93 M | 9.93 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 12.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Apollo Endosurgery, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical devices sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Butterfly Network
BFLY
|
$ 4.19 | 5.67 % | $ 887 M | ||
|
InMode Ltd.
INMD
|
$ 13.73 | 1.48 % | $ 887 M | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | ||
|
Bruker Corporation
BRKR
|
$ 34.86 | 4.68 % | $ 5.19 K | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
$ 9.51 | 5.32 % | $ 269 M | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | ||
|
Alphatec Holdings
ATEC
|
$ 12.15 | -1.78 % | $ 1.82 B | ||
|
Delcath Systems
DCTH
|
$ 9.1 | 0.33 % | $ 326 M | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
$ 31.75 | 3.15 % | $ 1.46 B | ||
|
Establishment Labs Holdings
ESTA
|
$ 59.61 | -4.85 % | $ 1.77 B | ||
|
CONMED Corporation
CNMD
|
$ 36.63 | 1.92 % | $ 1.14 B | ||
|
Edwards Lifesciences Corporation
EW
|
$ 82.02 | -0.58 % | $ 48 B | ||
|
Electromed
ELMD
|
$ 24.49 | 5.2 % | $ 207 M | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.67 | 2.06 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
$ 2.3 | 6.48 % | $ 3.59 M | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | ||
|
Helius Medical Technologies
HSDT
|
$ 2.06 | 0.98 % | $ 1.25 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.43 | 5.48 % | $ 726 M | ||
|
AdaptHealth Corp.
AHCO
|
$ 10.37 | 4.64 % | $ 1.4 B | ||
|
IRIDEX Corporation
IRIX
|
$ 1.35 | - | $ 21.8 M | ||
|
IRadimed Corporation
IRMD
|
$ 99.2 | -0.3 % | $ 1.26 B | ||
|
FONAR Corporation
FONR
|
$ 18.34 | -0.22 % | $ 120 M | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.73 | 3.32 % | $ 139 M | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.47 | -0.3 % | $ 386 M | ||
|
Inspire Medical Systems
INSP
|
$ 52.16 | -2.9 % | $ 1.53 B | ||
|
LivaNova PLC
LIVN
|
$ 63.24 | 1.69 % | $ 3.45 B | ||
|
Medtronic PLC
MDT
|
$ 87.17 | 1.13 % | $ 112 B | ||
|
Pulmonx Corporation
LUNG
|
$ 1.39 | 2.21 % | $ 56.6 M | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | ||
|
Myomo
MYO
|
$ 0.71 | 0.08 % | $ 29.7 M | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K |